Nemes Rush Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Buy |
5,723
+977
| +21% | +$435K | 0.28% | 65 |
|
|
2025
Q1 | $2.3M | Sell |
4,746
-112
| -2% | -$54.3K | 0.29% | 59 |
|
|
2024
Q4 | $1.96M | Buy |
4,858
+142
| +3% | +$57.2K | 0.24% | 65 |
|
|
2024
Q3 | $1.97M | Sell |
4,716
-9
| -0.2% | -$3.76K | 0.29% | 65 |
|
|
2024
Q2 | $2.21M | Buy |
4,725
+9
| +0.2% | +$4.22K | 0.3% | 58 |
|
|
2024
Q1 | $1.97M | Sell |
4,716
-18
| -0.4% | -$7.52K | 0.28% | 65 |
|
|
2023
Q4 | $1.93M | Sell |
4,734
-32
| -0.7% | -$13K | 0.31% | 62 |
|
|
2023
Q3 | $1.66M | Sell |
4,766
-18
| -0.4% | -$6.26K | 0.3% | 67 |
|
|
2023
Q2 | $1.68M | Buy |
+4,784
| New | +$1.68M | 0.3% | 69 |
|